Skip to main content
Top
Published in: Acta Neurochirurgica 8/2021

01-08-2021 | Cerebral Sinus Venous Thrombosis | Case Report - Vascular Neurosurgery - Other

Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine

Authors: Zaitun Zakaria, Nur Asma Sapiai, Abdul Rahman Izaini Ghani

Published in: Acta Neurochirurgica | Issue 8/2021

Login to get access

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology, the Pfizer/BioNTech vaccine is one of the vaccines been approved by the Drug Control Authority in Malaysia. Herein, we report an immediate complication of cerebral VST after the first dose of the Pfizer/BioNTech vaccine.
Literature
1.
go back to reference Abdalkader M, Shaikh SP, Siegler JE, Cervantes-Arslanian AM, Tiu C, Radu RA, Tiu VE, Jillella DV, Mansour OY, Vera V, Chamorro Á, Blasco J, López A, Farooqui M, Thau L, Smith A, Gutierrez SO, Nguyen TN, Jovin TG (2021) Cerebral venous sinus thrombosis in COVID-19 patients: a multicenter study and review of literature. J Stroke Cerebrovasc Dis 30(6):105733CrossRef Abdalkader M, Shaikh SP, Siegler JE, Cervantes-Arslanian AM, Tiu C, Radu RA, Tiu VE, Jillella DV, Mansour OY, Vera V, Chamorro Á, Blasco J, López A, Farooqui M, Thau L, Smith A, Gutierrez SO, Nguyen TN, Jovin TG (2021) Cerebral venous sinus thrombosis in COVID-19 patients: a multicenter study and review of literature. J Stroke Cerebrovasc Dis 30(6):105733CrossRef
2.
go back to reference Abouhashem S, Eldawoody H, Taha MM (2021) Cerebral venous sinus thrombosis in patients with COVID-19 infection. Interdiscip Neurosurg 24:101091CrossRef Abouhashem S, Eldawoody H, Taha MM (2021) Cerebral venous sinus thrombosis in patients with COVID-19 infection. Interdiscip Neurosurg 24:101091CrossRef
3.
go back to reference Carli G, Nichele I, Ruggeri M, Barra S, Tosetto A (2021) Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Intern Emerg Med 16(3):803–804 Carli G, Nichele I, Ruggeri M, Barra S, Tosetto A (2021) Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Intern Emerg Med 16(3):803–804
4.
go back to reference Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K, Nossek E, Torres J, Jain R, Riina HA, Radmanesh A, Nelson PK (2020) Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol 41(8):1370–1376CrossRef Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K, Nossek E, Torres J, Jain R, Riina HA, Radmanesh A, Nelson PK (2020) Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol 41(8):1370–1376CrossRef
5.
go back to reference Cui S, Chen S, Li X, Liu S, Wang F (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 18(6):1421–1424CrossRef Cui S, Chen S, Li X, Liu S, Wang F (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 18(6):1421–1424CrossRef
7.
go back to reference Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K (2020) Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol 189(5):846–847CrossRef Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K (2020) Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol 189(5):846–847CrossRef
8.
go back to reference Liu J, Thorp SC (2002) Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev 22(1):1–25CrossRef Liu J, Thorp SC (2002) Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev 22(1):1–25CrossRef
9.
go back to reference Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT, Barco S (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9–14CrossRef Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT, Barco S (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9–14CrossRef
10.
go back to reference Longchamp A, Longchamp J, Manzocchi-Besson S, Whiting L, Haller C, Jeanneret S, Godio M, Garcia Martinez JJ, Bonjour T, Caillat M, Maitre G, Thaler JM, Pantet R, Donner V, Dumoulin A, Emonet S, Greub G, Friolet R, Robert-Ebadi H, Righini M, Sanchez B, Delaloye J (2020) Venous thromboembolism in critically ill patients with COVID-19: results of a screening study for deep vein thrombosis. Res Pract Thromb Haemost 4(5):842–847CrossRef Longchamp A, Longchamp J, Manzocchi-Besson S, Whiting L, Haller C, Jeanneret S, Godio M, Garcia Martinez JJ, Bonjour T, Caillat M, Maitre G, Thaler JM, Pantet R, Donner V, Dumoulin A, Emonet S, Greub G, Friolet R, Robert-Ebadi H, Righini M, Sanchez B, Delaloye J (2020) Venous thromboembolism in critically ill patients with COVID-19: results of a screening study for deep vein thrombosis. Res Pract Thromb Haemost 4(5):842–847CrossRef
11.
go back to reference Obi AT, Tignanelli CJ, Jacobs BN, Arya S, Park PK, Wakefield TW, Henke PK, Napolitano LM (2019) Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord 7(3):317–324CrossRef Obi AT, Tignanelli CJ, Jacobs BN, Arya S, Park PK, Wakefield TW, Henke PK, Napolitano LM (2019) Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord 7(3):317–324CrossRef
12.
go back to reference Østergaard SD, Schmidt M, Horváth-Puhó E, Thomsen RW, Sørensen HT (2021) Thromboembolism and the Oxford-Astrazeneca COVID-19 vaccine: side-effect or coincidence? Lancet 397(10283):1441–1443 Østergaard SD, Schmidt M, Horváth-Puhó E, Thomsen RW, Sørensen HT (2021) Thromboembolism and the Oxford-Astrazeneca COVID-19 vaccine: side-effect or coincidence? Lancet 397(10283):1441–1443
13.
go back to reference Ostovan VR, Foroughi R, Rostami M, Almasi-Dooghaee M, Esmaili M, Bidaki AA, Behzadi Z, Farzadfard F, Marbooti H, Rahimi-Jaberi A, Poursadeghfard M, Fadakar N, Bayat M, Owjfard M, Salehi MS, Zafarmand SS, Mardi F, Safari A, Shahjouei S, Mowla A, Azarpazhooh MR, Zand R, Hooshmandi E, Borhani-Haghighi A (2021) Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review. J Neurol. https://doi.org/10.1007/s00415-021-10450-8 Ostovan VR, Foroughi R, Rostami M, Almasi-Dooghaee M, Esmaili M, Bidaki AA, Behzadi Z, Farzadfard F, Marbooti H, Rahimi-Jaberi A, Poursadeghfard M, Fadakar N, Bayat M, Owjfard M, Salehi MS, Zafarmand SS, Mardi F, Safari A, Shahjouei S, Mowla A, Azarpazhooh MR, Zand R, Hooshmandi E, Borhani-Haghighi A (2021) Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review. J Neurol. https://​doi.​org/​10.​1007/​s00415-021-10450-8
14.
go back to reference Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattør TH, Tjønnfjord GE, Holme PA (2021) Thrombosis and thrombocytopenia after chadox1 nCov-19 vaccination. N Engl J Med. https://doi.org/10.1056/NEJMoa2104882 Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattør TH, Tjønnfjord GE, Holme PA (2021) Thrombosis and thrombocytopenia after chadox1 nCov-19 vaccination. N Engl J Med. https://​doi.​org/​10.​1056/​NEJMoa2104882
15.
go back to reference Strizova Z, Smetanova J, Bartunkova J, Milota T (2021) Principles and challenges in anti-COVID-19 vaccine development. Int Arch Allergy Immunol 182(4):339–349CrossRef Strizova Z, Smetanova J, Bartunkova J, Milota T (2021) Principles and challenges in anti-COVID-19 vaccine development. Int Arch Allergy Immunol 182(4):339–349CrossRef
16.
go back to reference Umair S, Waqas U, Faheem M (2021) COVID-19 pandemic: stringent measures of Malaysia and implications for other countries. Postgrad Med J 97(1144):130–132CrossRef Umair S, Waqas U, Faheem M (2021) COVID-19 pandemic: stringent measures of Malaysia and implications for other countries. Postgrad Med J 97(1144):130–132CrossRef
Metadata
Title
Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
Authors
Zaitun Zakaria
Nur Asma Sapiai
Abdul Rahman Izaini Ghani
Publication date
01-08-2021
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 8/2021
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-021-04860-w

Other articles of this Issue 8/2021

Acta Neurochirurgica 8/2021 Go to the issue